Image quality derived from echo liver imaging at 3T (A, left) improves (A, right) when applying Philips MultiTransmit technology, which eliminatesdielectric shading, an artifact commonly found at this field strength.
Image quality derived from echo liver imaging at 3T (A) improves when applying Philips MultiTransmit technology, which eliminates dielectric shading, an artifact commonly found at this field strength. Unveiled at RSNA 2008, MultiTransmit technology automatically adjusts multiple radiofrequency signals to accommodate the anatomy of specific patients, thereby improving image uniformity and increasing overall image consistency, according to the company. The technology, which is unique to the company’s Achieva 3.0T TX, is particularly helpful in patients with liver cirrhosis and ascites (B). These ascites can be challenging to image due to shielding effects of fluids (B, inset). MultiTransmit solves the problem, decreasing B1 inhomogeneity and, thereby, improving lesion visualization. The first installations of the Achieva 3.0T TX with MultiTransmit began operating earlier this year at Tokai University in Tokyo, Bonn University in Germany, and Fletcher Allen Health Care in Burlington, VT. Users are focusing on breast, spine, and abdominal imaging. (Provided by University of Bonn)
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.